Costa Dalis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Costa Dalis has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Fikir M. Mesfin
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA
1 shared publication - Jianyun Liu
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, USA
1 shared publication - John P. Brokaw
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA
1 shared publication - Krishna Manohar
Department of Surgery, Indiana University School of Medicine (IUSM), Indianapolis, USA
1 shared publication - Troy A. Markel
Department of Surgery, Section of Pediatric Surgery, Indiana University School of Medicine, Indianapolis, IN, USA; Riley Hospital for Children at Indiana University Health, Indianapolis, IN, USA
1 shared publication - W. Christopher Shelley
Department of Pediatrics, Indiana University School of Medicine , Indianapolis, IN, 46202
1 shared publication
Latest Publications
- Open Access
- 17 July 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (7) , 1822
Volatile Organic Compound Assessment as a Screening Tool for Early Detection of Gastrointestinal Diseases
Gastrointestinal (GI) diseases have a high prevalence throughout the United States. Screening and diagnostic modalities are often expensive and invasive, and therefore, people do not utilize them effectively. Lack of proper screening and diagnostic assessment may lead to delays in diagnosis, more advanced disease at the time of diagnosis, and higher morbidity and mortality rates. Research on the intestinal microbiome has demonstrated that dysbiosis, or unfavorable alteration of organismal composition, precedes the onset of clinical symptoms for various GI diseases. GI disease diagnostic research has led to a shift towards non-invasive methods for GI screening, including chemical-detection tests that measure changes in volatile organic compounds (VOCs), which are the byproducts of bacterial metabolism that result in the distinct smell of stool. Many of these tools are expensive, immobile benchtop instruments that require highly trained individuals to interpret the results. These attributes make them difficult to implement in clinical settings. Alternatively, electronic noses (E-noses) are relatively cheaper, handheld devices that utilize multi-sensor arrays and pattern recognition technology to analyze VOCs. The purpose of this review is to (1) highlight how dysbiosis impacts intestinal diseases and how VOC metabolites can be utilized to detect alterations in the microbiome, (2) summarize the available VOC analytical platforms that can be used to detect aberrancies in intestinal health, (3) define the current technological advancements and limitations of E-nose technology, and finally, (4) review the literature surrounding several intestinal diseases in which headspace VOCs can be used to detect or predict disease.
- 17 July 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (7) , 1822
Open AccessVolatile Organic Compound Assessment as a Screening Tool for Early Detection of Gastrointestinal Diseases
Gastrointestinal (GI) diseases have a high prevalence throughout the United States. Screening and diagnostic modalities are often expensive and invasive, and therefore, people do not utilize them effectively. Lack of proper screening and diagnostic assessment may lead to delays in diagnosis, more advanced disease at the time of diagnosis, and higher morbidity and mortality rates. Research on the intestinal microbiome has demonstrated that dysbiosis, or unfavorable alteration of organismal composition, precedes the onset of clinical symptoms for various GI diseases. GI disease diagnostic research has led to a shift towards non-invasive methods for GI screening, including chemical-detection tests that measure changes in volatile organic compounds (VOCs), which are the byproducts of bacterial metabolism that result in the distinct smell of stool. Many of these tools are expensive, immobile benchtop instruments that require highly trained individuals to interpret the results. These attributes make them difficult to implement in clinical settings. Alternatively, electronic noses (E-noses) are relatively cheaper, handheld devices that utilize multi-sensor arrays and pattern recognition technology to analyze VOCs. The purpose of this review is to (1) highlight how dysbiosis impacts intestinal diseases and how VOC metabolites can be utilized to detect alterations in the microbiome, (2) summarize the available VOC analytical platforms that can be used to detect aberrancies in intestinal health, (3) define the current technological advancements and limitations of E-nose technology, and finally, (4) review the literature surrounding several intestinal diseases in which headspace VOCs can be used to detect or predict disease.